Vaccine research, development, and innovation in Brazil: A translational science perspective

Highlights ► This article updates the Brazilian national capacity for innovation. ► The scientific, technological and industrial policies for vaccine development and production are discussed. ► The results indicate significant progress, but with important gaps that must be overcome for a rapid incre...

Full description

Saved in:
Bibliographic Details
Published inVaccine Vol. 31; pp. B54 - B60
Main Authors Homma, Akira, Tanuri, Amilcar, Duarte, Alberto J.S, Marques, Ernesto, de Almeida, Alexandre, Martins, Reinaldo, Silva-Junior, Jarbas B, Possas, Cristina
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 18.04.2013
Subjects
Allergy and Immunology
Brazil
Brazilian immunization program
Developing countries
Government Programs
Health Policy - legislation & jurisprudence
Humans
Immunization Programs - legislation & jurisprudence
Immunization Programs - statistics & numerical data
infectious diseases
Innovation
Inventions
issues and policy
Public Health
Public-Private Sector Partnerships
research and development
Technology Transfer
Translational Medical Research
Translational sciences
Vaccines
Brazil
Brazilian immunization program
Innovation
Vaccines
Translational sciences
Online AccessGet full text

Cover

More Information
Summary:Highlights ► This article updates the Brazilian national capacity for innovation. ► The scientific, technological and industrial policies for vaccine development and production are discussed. ► The results indicate significant progress, but with important gaps that must be overcome for a rapid increase in vaccine research. ► The new Industrial Health Complex Program is presented as a crucial player to bridge these gaps. ► The links between scientific and technological policies should be strengthened to accelerate innovation and development of new vaccine products.
Bibliography:http://dx.doi.org/10.1016/j.vaccine.2012.11.084
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ObjectType-Feature-1
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2012.11.084